Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Trial of Intravenous Iron in Cystic Fibrosis
NCT03632525Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Feb 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by University of Oxford. Primary endpoint: Incidence of new infective events at 8 weeks. Started Feb 2019; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03632525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03632525.